To commercialise distinctive and ground-breaking products in the areas of Maternal Health & Urology, CORONA Remedies Private Limited (CORONA) has entered into an agreement with Ferring Pharmaceuticals Pvt. Ltd. (Ferring), a subsidiary of global...
Zion Pharma Limited, a Chinese biotechnology firm specialising in the creation of substances that may penetrate the brain, revealed today that Roche has purchased the worldwide rights to Zion's principal programme, ZN-A-1041. ZN-A-1041 is a Human...
Germany's BioNTech, a collaborator with Pfizer on the COVID-19 vaccinations, reported that decreasing demand for the shots contributed to a decline in first-quarter net income as it expanded its work on cancer and other disorders. In order to...
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, announced that it has received a "Day 74" notification from the US Food and Drug Administration (FDA) confirming that the previously submitted New Drug Application....
Norlase, a leading global ophthalmic laser manufacturer developing next-generation laser solutions, announced that the ECHO Green Pattern Laser photocoagulator has received both FDA 510(k) clearance and CE Mark approval...
The European Union should put in place systems that allow drugmakers to charge higher pricing in wealthy European countries and lower costs in poorer countries to ensure more fair patient access to life-saving medications, according to Bayer's...
Alembic Pharmaceuticals Ltd, an Indian generic drugmaker, announced a nearly seven-fold increase in fourth-quarter profit on Friday, aided by decreased expenses and high revenues from its domestic drug-making sector...
Technologies are revolutionizing the way veterinarians diagnose and treat diseases in animals. Veterinary medicine embraces these technologies to provide more efficient and cost-effective medical care.
Amphista Therapeutics, a pioneer in next-generation targeted protein degradation (TPD) techniques, reported the achievement of the first discovery milestone under its cooperation and licence agreement with Bristol Myers Squibb, triggering...
The approval granted by the US Food and Drug Administration (USFDA) is to manufacture and market Sucralfate Tablets of strength 1 gram, Zydus Lifesciences said in a regulatory filing. The drug will be manufactured at the group's topical...
, CDSCO.jpg)
